APG Asset Management N.V. Has $107.10 Million Stake in Colgate-Palmolive Company $CL

APG Asset Management N.V. decreased its stake in shares of Colgate-Palmolive Company (NYSE:CL) by 9.5% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 1,234,714 shares of the company’s stock after selling 129,987 shares during the quarter. APG Asset Management N.V.’s holdings in Colgate-Palmolive were worth $107,103,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors also recently modified their holdings of CL. Cornerstone Wealth Management LLC grew its position in Colgate-Palmolive by 1.2% in the 1st quarter. Cornerstone Wealth Management LLC now owns 9,035 shares of the company’s stock valued at $847,000 after purchasing an additional 110 shares during the period. Aberdeen Wealth Management LLC grew its position in Colgate-Palmolive by 0.6% in the 4th quarter. Aberdeen Wealth Management LLC now owns 20,651 shares of the company’s stock valued at $1,877,000 after purchasing an additional 125 shares during the period. Town & Country Bank & Trust CO dba First Bankers Trust CO grew its position in Colgate-Palmolive by 4.0% in the 1st quarter. Town & Country Bank & Trust CO dba First Bankers Trust CO now owns 3,388 shares of the company’s stock valued at $317,000 after purchasing an additional 130 shares during the period. Continuum Advisory LLC grew its position in Colgate-Palmolive by 17.2% in the 4th quarter. Continuum Advisory LLC now owns 893 shares of the company’s stock valued at $81,000 after purchasing an additional 131 shares during the period. Finally, KFG Wealth Management LLC grew its position in Colgate-Palmolive by 1.5% in the 1st quarter. KFG Wealth Management LLC now owns 8,835 shares of the company’s stock valued at $828,000 after purchasing an additional 131 shares during the period. Institutional investors and hedge funds own 80.41% of the company’s stock.

Colgate-Palmolive Price Performance

Shares of NYSE:CL opened at $85.7790 on Friday. The company’s 50-day moving average is $87.60 and its 200 day moving average is $89.91. The company has a debt-to-equity ratio of 6.79, a quick ratio of 0.57 and a current ratio of 0.89. The company has a market capitalization of $69.33 billion, a P/E ratio of 24.10, a price-to-earnings-growth ratio of 4.49 and a beta of 0.35. Colgate-Palmolive Company has a fifty-two week low of $82.40 and a fifty-two week high of $109.30.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings results on Friday, August 1st. The company reported $0.92 earnings per share for the quarter, topping analysts’ consensus estimates of $0.89 by $0.03. The company had revenue of $5.11 billion for the quarter, compared to the consensus estimate of $5.03 billion. Colgate-Palmolive had a net margin of 14.55% and a return on equity of 377.63%. The firm’s quarterly revenue was up 1.0% on a year-over-year basis. During the same period in the previous year, the firm earned $0.91 EPS. On average, equities research analysts forecast that Colgate-Palmolive Company will post 3.75 earnings per share for the current year.

Colgate-Palmolive Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, August 15th. Investors of record on Friday, July 18th were issued a $0.52 dividend. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.4%. The ex-dividend date of this dividend was Friday, July 18th. Colgate-Palmolive’s payout ratio is 58.43%.

Wall Street Analyst Weigh In

Several research firms recently issued reports on CL. Wall Street Zen downgraded shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research report on Wednesday, May 7th. Barclays lifted their price target on shares of Colgate-Palmolive from $86.00 to $87.00 and gave the company an “equal weight” rating in a research report on Tuesday, July 15th. JPMorgan Chase & Co. reduced their price target on shares of Colgate-Palmolive from $99.00 to $95.00 and set an “overweight” rating for the company in a research report on Monday, August 4th. Wells Fargo & Company dropped their price objective on Colgate-Palmolive from $88.00 to $83.00 and set an “underweight” rating on the stock in a research note on Monday, August 4th. Finally, UBS Group dropped their price objective on Colgate-Palmolive from $109.00 to $106.00 and set a “buy” rating on the stock in a research note on Thursday, July 17th. Seven investment analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $98.92.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.